Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop? ; volume:122 ; number:03 ; year:2022 ; pages:311-314
Thrombosis and haemostasis ; 122, Heft 03 (2022), 311-314
- Beteiligte Personen und Organisationen
- DOI
-
10.1055/s-0041-1740639
- URN
-
urn:nbn:de:101:1-2022042811324926761908
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Ähnliche Objekte (12)
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Aspirin for Prevention of Preeclampsia
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
Spontaneous Preterm Birth: Is Prevention with Aspirin Possible?
Missed opportunities in aspirin prescribing for preeclampsia prevention
Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Aspirin for Prevention of Preeclampsia
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
Spontaneous Preterm Birth: Is Prevention with Aspirin Possible?
Missed opportunities in aspirin prescribing for preeclampsia prevention
Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Aspirin for Prevention of Preeclampsia
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
Spontaneous Preterm Birth: Is Prevention with Aspirin Possible?
Missed opportunities in aspirin prescribing for preeclampsia prevention